English  |  Español

Skip Navigation Links

Skip Navigation Links

Women and Cancer
Women and Violence
Help Now
About Us
The Mary Kay Foundation
2012 Cancer Grant Recipients

Jacob Berlin, Ph.D., City of Hope
Title of Project: Stem Cell-Mediated Targeted Therapy for Triple Negative Breast Cancer

Rolf A. Brekken, Ph.D., UT Southwestern Medical Center, Dallas
Title of Project: ALK as a driver of breast cancer metastasis

Alfred I.J. Bothwell, Ph.D., Yale University
Title of Project: Modeling of Human Immune System Interaction with Breast Tumors and Treatments in Mice

Eric C. Chang, Ph.D., Baylor College of Medicine
Title of Project: N-Ras as a key regulator and potential treatment target for basal-like breast cancer

Gerald R. Crabtree, Ph.D., Stanford University
Title of Project: Targeting Ovarian Cancer via Cooperative Oncogene Interactions

Paloma H. Giangrande, Ph.D., University of Iowa
Title of Project: Multifunctional RNA-based Reagents for the Treatment of Ovarian Cancer

Andrew K. Godwin, Ph.D., University of Kansas Medical Center
Title of Project: High-Throughput Microfluidic Exosome Profiling Platform for Early Detection of Ovarian Cancer

William Hahn, Ph.D., Dana-Farber Cancer Institute, Harvard
Title of Project: Genomic Characterization of Brain Metastases from Breast Cancer

David Sherr, Ph.D., Boston University Medical Center
Title of Project: A Novel AhR-Targeted Therapeutic for Triple Negative and Chemo-Resistant Breast Cancers

Barry Sleckman, Ph.D., Washington University School of Medicine
Title of Project: Identification of Novel DNA double strand break repair targeting therapeutics for the treatment of breast cancer

LuZhe Sun, Ph.D., UT Health Science Center at San Antonio
Title of Project: Bisphenol A and Breast Cancer – Effect on Mammary Stem Cell and its Niche

John J. Turchi, Ph.D., Indiana University
Title of Project: Rational, biology-based combination therapy for the treatment of ovarian cancer

Deric Wheeler, Ph.D., Wisconsin Institute for Medical Research
Title of Project: Targeting Nuclear EGFR: Strategies for improving cetuximab therapy in triple-negative breast cancer

Women and Cancer
Resources & Information
Inspiring Stories
Research Grant Program
Our Cancer Grants at Work
Women and Violence
Resources & Programs
Inspiring Stories
Shelter Grant Program
Our Shelter Grants at Work
Help Now
Contribute Now
Gift and Resource Items
Other Ways to Help
Planned Giving
Upcoming Events
Event Highlights
Host an Event
Recent Events
About Us
Contact Us
Corporate Partner

News & Awards
Our History
Mary Kay Inc. is the major corporate sponsor of The Mary Kay Foundation. Because of the Company’s generous support, more than 97 percent of dollars donated by supporters like you can go directly to programs and research. Less than three percent goes to administrative and overhead costs.
© 2009 The Mary Kay Foundation